Egazini, abafazi abakhulelweyo akufanele baqulathe nayiphi na i-microorganisms okanye iintsholongwane, njengoko zinokubangela ukungaphumeleli kokuphuhliswa, izifo ezithintekayo zangaphakathi , kunye nokufa kwakhe.
Yintoni eyingozi kwi-chlamydia kwabasetyhini abakhulelweyo?
Nangona loo ntokazi ayiguli, kodwa kuphela umthwali we-chlamydia, ukukhulelwa kwangaphambili kunokukhokelela ekulahlekeni kwamathambo kunye nokukhula, kwaye emva kwexesha-ukuzalwa kwangaphambi kokuzalwa, ukusuleleka komntwana ekuzalweni kokuzala kunye nokuphuhliswa kwezifo ezahlukahlukeneyo ezikhuphayo zesikhumba kunye nephepha eliphezulu lokuphefumula. Ukongeza, i-chlamydia inokubangela ukuba i-toxicosis ekhuselekileyo kubasetyhini abakhulelweyo, kubangele ukukhulelwa komntwana obushushu, ukuphazamiseka kwentsholongwane kwi-placenta.
I-Chlamydia egazini ngexesha lokukhulelwa - ukuxilongwa
Ukuxilongwa kokuhamba, ukuhlolwa kwegazi kumagciwane okulwa ne-chlamydiae kwenziwa, ukutyhila ukubaluleka kwesihloko sabo ngexesha lokukhulelwa. Ukuba ukuhlalutya kwe-chlamydia kubonisa i-anti-personic titer titer ekukhulelwe, ngoko kuphela ukuhamba kwe-chlamydia kuyafunyanwa ngaphandle kokuphuhlisa okanye ukunyusa isifo. Kuphela ngezihloko eziphezulu ze-antibodies ziyakwazi ukuxilonga isifo kwaye zenzele unyango. Kodwa indlela eyodwa kuphela ye-antibody titer egazini labasetyhini abakhulelweyo ayiqinisekisi ukuxilongwa, i-chlamydia kufuneka ifumaneke nge-microscopy ye-smear evela kwinqanawa yomlomo wesibeleko.
Unyango lwe-chlamydia kwabasetyhini abakhulelweyo
Ukwelashwa kwe- chlamydia ekukhulelweni kunqunywe kuphela kwizihloko eziphezulu ze-antibodies egazini ukuya kwi-chlamydia (IgA 1:40 no-IgG 1:80), kwaye ukuba izihloko zingaphantsi kwe-1: 5, kwaye kwi-smear evela kwisigodlo somlomo wesi-chlamydia ayifumanwanga, engaphathwa ngexesha lokukhulelwa. Kodwa ukuba kuyimfuneko, amayeza e-macrolide anqunyiwe, emva koko i-anttifital agents ingasetyenziselwa ukuthintela i-dysbacteriosis. Ukomeleza ukhuseleko, abasetyhini banqunyulwa ngokubanzi kwi-multivitamines kunye ne-immunostimulants.